Analysis of discharge performed by the COVID-19 remote monitoring team in the City of Piauí

Authors

DOI:

https://doi.org/10.33448/rsd-v9i8.5876

Keywords:

Coronavirus infections; Signs and symptons; Pandemics.

Abstract

The objective of the study is to present epidemiological data related to the closure of the first 197 cases of the remote monitoring service for patients with confirmed cases of COVID-19 in the city of Parnaiba-PI. It is a quantitative epidemiological study that followed approximately 950 patients with suspected cases of COVID-19 for 2 months, with epidemiological confirmation of 197 cases, where 196 of them were discharged from the service and 1 died. Analyzing the data of the patients who were discharged, it was observed that there was no difference in terms of gender distribution, the most affected age group was between 20 and 40 years and that most individuals did not have any associated comorbidity. Of the total number of patients, 142 underwent pharmacological treatment, of which only 26 had any side effects. The results obtained regarding the frequency of side effects were similar to data in the literature, as well as the incidence of frequency of symptoms also showed similarities in relation to data in the world literature. Of the total number of patients analyzed in the study, only 5 patients required hospitalization, showing that the syndromic surveillance system showed good results, being a way to intervene early and reduce the risk of worsening the disease.

References

Almeida, J. S., Cardoso, J. A., Cordeiro, E. C., Lemos, M., de Araújo, T. M. E., & Sardinha, A. H. L. (2020). Caracterização epidemiológica dos casos de COVID-19 no Maranhão: uma breve análise epidemiológica.

Alonso, W. J., Schuck-Paim, C., Freitas, A. R. R., Kupek, E., Wuerzius, C. R., Negro-Calduch, E., ... &Abrao, M. S. (2020). Covid-19 em contexto: comparação com a mortalidade mensal por causas respiratórias nos estados brasileiros. InterAmerican Journal of Medicine and Health, 3, 1-21.

Ashraf, M. A., Shokouhi, N., Shirali, E., Davari-tanha, F., Memar, O., Kamalipour, A., & Azad, T. M. (2020). COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes. medRxiv.

Barjud, M. B., et al. Protocolo para atendimento da COVID-19 no pronto atendimento. Médicos do Piauí. 2020.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., & Yu, T. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395(10223), 507-513.

Costa, I. B. S. D. S., Bittar, C. S., Rizk, S. I., Araújo Filho, A. E. D., Santos, K. A. Q., Machado, T. I. V., & Bacal, F. (2020). O Coração e a COVID-19: O que o Cardiologista Precisa Saber. Arquivos Brasileiros de Cardiologia, 114(5), 805-816.

Carvalho, B. R., Cunha filho, J. S., Michelon, J., Samama, M., Amaral, M. E. B., Souza, P. M. G., ... & Adami, K. (2020). Relação entre Covid-19 e TRA. Editor: Lister de Lima Salgueiro, 134.

Derwand, R., & Scholz, M. (2020). Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win todays battle against COVID-19?.Medical Hypotheses, 109815.

Dias, F. A., Pereira, E. R., & Silva, R. M. C. R. A. (2020). Public Health and the COVID-19 pandemic: challenges for global health. Research, Society andDevelopment, 9(7), 321974188.

Esper, R. B.; et al. (2020). Tratamento empírico com hidroxicloroquina e azitromicina para suspeita de casos de COVID-19 acompanhados por telemedicina.

Freitas, A. R. R.; Napipmoga, M. &Donalisio, M. R. (2020). Análise da gravidade da pandemia de Covid-19. Epidemiologia e Serviços de Saúde, 29, e2020119.

Geleris, J., Sun, Y., Platt, J., Zucker, J., Baldwin, M., Hripcsak, G., & Sobieszczyk, M. E. (2020). Observational study of hydroxychloroquine in hospitalized patients with Covid-19. New England Journal of Medicine.

Gong, M.,et al. cloud-based system for effective surveillance and control of covid-19: usefulexperiences from Hubei, China, 22(4), 2020.

Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., & Du, B. (2020). Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, 382(18), 1708-1720.

Habibzadeh, P., & Stoneman E. K. The novel coronavirus: a bird’s eye view. International Journal of Occupational and Environmental. Medicine, 11(2).

Hou, W., Zhang, W., Jin, R., Liang, L., Xu, B., & Hu, Z. (2020). Risk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study. Infectious Diseases, 1-8.

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., & Cheng, Z. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506.

Instituto Brasileiro de Geografia e Estatística. (2010). Cidades e Estados. Rio de Janeiro: IBGE. Available on: https://www.ibge.gov.br/cidades-e-estados/pi/parnaiba.html.

Lana, R. M., Coelho, F. C., Gomes, M. F. D. C., Cruz, O. G., Bastos, L. S., Villela, D. A. M., & Codeço, C. T. (2020). Emergência do novo coronavírus (SARS-CoV-2) e o papel de uma vigilância nacional em saúde oportuna e efetiva. Cadernos de Saúde Pública, 36, e00019620.

Lima, D. L. F., Dias, A. A., Rabelo, R. S., Cruz, I. D. D., Costa, S. C., Nigri, F. M. N., & Neri, J. R. (2020). COVID-19 no estado do Ceará, Brasil: comportamentos e crenças na chegada da pandemia. Ciência & Saúde Coletiva, 25, 1575-1586.

Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., & Miao, X. (2020). Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA neurology, 77(6), 683-690.

Meo, S. A., Klonoff, D. C., & Akram, J. (2020). Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19. EurRevMedPharmacolSci, 24(8), 4539-4547.

Million M., et al. (2020). Tratamento precoce de pacientes COVID-19 com hidroxicloroquina e azitromicina: uma análise retrospectiva de 1061 casos em Marselha, França. Medicina de viagem e doenças infecciosas.

Pimentel, R. M. M., Daboin, B. E. G., de Oliveira, A. G., & Macedo Jr, H. (2020). The dissemination of COVID-19: an expectant and preventive role in global health. Journal of Human Growth and Development, 30(1), 135-140.

Schmith, V. D., Zhou, J., & Lohmer, L. R. (2020). The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID‐19. Clinical Pharmacology & Therapeutics.

Tang, W., Cao, Z., Han, M., Wang, Z., Chen, J., Sun, W., ... & Chen, W. (2020). Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial. MedRxiv.

Thompson, R. N., Lovell-Read, F. A., & Obolski, U. (2020). Time from Symptom Onset to Hospitalisation of Coronavirus Disease 2019 (COVID-19) Cases: Implications for the Proportion of Transmissions from Infectors with Few Symptoms. Journal of Clinical Medicine, 9(5), 1297.

Yang, C. L., Qiu, X., Zeng, Y. K., Jiang, M., Fan, H. R., & Zhang, Z. M. (2020). Coronavirus disease 2019: a clinical review. European Review for Medical and Pharmacological Sciences, 24(8).

Walls, A. C., Park, Y. J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell.

World Health Organization. (2020). Coronavirus disease 2019 (COVID-2019) situation reports - 153. 2020. Available on: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200621-covid-19-sitrep-153.pdf?sfvrsn=c896464d_2

Downloads

Published

13/07/2020

How to Cite

BELTRÃO, R. P. L.; SILVA, A. C. B. da; MOUTA, A. A. N.; FLORÊNCIO, P. C. M.; BELTRÃO, B. C. R.; COUTO, R. N.; OLIVEIRA, J. E. N.; LOPES, S. D. S.; LIMA, D. A.; COSTA, C. P. M.; RIGAMONTE, N. G. dos S.; BELTRÃO, C. M. F.; SILVA, D. F. B. da; BEZERRA, D. M.; BELTRÃO, I. T.; ALMENDRA NETO, O. L. Analysis of discharge performed by the COVID-19 remote monitoring team in the City of Piauí. Research, Society and Development, [S. l.], v. 9, n. 8, p. e453985876, 2020. DOI: 10.33448/rsd-v9i8.5876. Disponível em: https://www.rsdjournal.org/index.php/rsd/article/view/5876. Acesso em: 24 apr. 2024.

Issue

Vol. 9 No. 8

Section

Health Sciences

License

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.